Evidence map›Paper›PMID 30318635›Full record

ArticleMolecular microbiology2019

Competition between DivIVA and the nucleoid for ParA binding promotes segrosome separation and modulates mycobacterial cell elongation.

Monika Pióro, Tomasz Małecki, Magda Portas, Izabela Magierowska, Damian Trojanowski, David Sherratt, Jolanta Zakrzewska-Czerwińska, Katarzyna Ginda, Dagmara Jakimowicz

Open access · hybridAbstract read
In one paragraph

Article in Molecular microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Protein Architecture and Composition in Mycobacterium tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. TipN's involvement with centromere segregation in Caulobacter crescentus.bioRxiv : the preprint server for biology · 2023
    Article
  4. Article
  5. Localization of EccABMC microbiology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Monika PióroLaboratory of Molecular Biology of Microorganisms, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Tomasz MałeckiFaculty of Biotechnology, Department of Molecular Microbiology, University of Wrocław, Wrocław, Poland.
Magda PortasFaculty of Biotechnology, Department of Molecular Microbiology, University of Wrocław, Wrocław, Poland.
Izabela MagierowskaFaculty of Biotechnology, Department of Molecular Microbiology, University of Wrocław, Wrocław, Poland.
Damian TrojanowskiFaculty of Biotechnology, Department of Molecular Microbiology, University of Wrocław, Wrocław, Poland.
David SherrattDepartment of Biochemistry, University of Oxford, Oxford, UK.
Jolanta Zakrzewska-CzerwińskaLaboratory of Molecular Biology of Microorganisms, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Katarzyna GindaFaculty of Biotechnology, Department of Molecular Microbiology, University of Wrocław, Wrocław, Poland.
Dagmara JakimowiczLaboratory of Molecular Biology of Microorganisms, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.ORCID 0000-0002-7857-064X
University of Wrocław · PLLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PLUniversity of Oxford · GB

Funding

Harmonia 2014/14/M/NZ1/00076Maestro funding scheme, National Science Centre 2012/04/A/NZ1/00057Narodowe Centrum Nauki 2012/04/A/NZ1/00057Narodowe Centrum Nauki 2014/14/M/NZ1/00076National Science Centre, PolandNational Science Centre, Poland 2014/14/M/NZ1/00076Polish Ministry of Science and Higher Education 1083/MOB/2013/0Wroclaw Centre of Biotechnology, programme of the Leading National Research Centre
6 · The paper itself

Abstract

Although mycobacteria are rod shaped and divide by simple binary fission, their cell cycle exhibits unusual features: unequal cell division producing daughter cells that elongate with different velocities, as well as asymmetric chromosome segregation and positioning throughout the cell cycle. As in other bacteria, mycobacterial chromosomes are segregated by pair of proteins, ParA and ParB. ParA is an ATPase that interacts with nucleoprotein ParB complexes - segrosomes and non-specifically binds the nucleoid. Uniquely in mycobacteria, ParA interacts with a polar protein DivIVA (Wag31), responsible for asymmetric cell elongation, however the biological role of this interaction remained unknown. We hypothesised that this interaction plays a critical role in coordinating chromosome segregation with cell elongation. Using a set of ParA mutants, we determined that disruption of ParA-DNA binding enhanced the interaction between ParA and DivIVA, indicating a competition between the nucleoid and DivIVA for ParA binding. Having identified the ParA mutation that disrupts its recruitment to DivIVA, we found that it led to inefficient segrosomes separation and increased the cell elongation rate. Our results suggest that ParA modulates DivIVA activity. Thus, we demonstrate that the ParA-DivIVA interaction facilitates chromosome segregation and modulates cell elongation.

Indexed as

Bacterial ProteinsCell Cycle ProteinsChromosome SegregationDNA, BacterialDNA Mutational AnalysisMycobacterium smegmatisBacterial ProteinsCell Cycle Proteinschromosome partition proteins, bacterialDivIVA protein, bacteriaDNA, Bacterial

Identifiers

PMID30318635
PMCPMC7379644
OpenAlexW2896417296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.